Global Drug Delivery Technology Market Research Report 2023

Publication ID:

PB503235442

Publication Date:

March 21, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Increasing prevalence of chronic diseases, increasing demand for biologics, technological advancements, and new product launches are some of the major factors driving the growth of the market.
Highlights
The global Drug Delivery Technology market was valued at US$ 515230 million in 2022 and is anticipated to reach US$ 648640 million by 2029, witnessing a CAGR of 3.9% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Self-administration & home care and rising demand for biosimilars and generic drugs offer significant growth opportunities for player operating in the market. On the Others hand, risk of needle-stick injuries and side effects of drugs may restraint the growth of the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Delivery Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery Technology.
The Drug Delivery Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drug Delivery Technology market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Delivery Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Johnson & Johnson Services
Novartis Ag
F.Hoffmann-La Roche Ltd.
Pfizer
Bayer Ag
Antares PharmA
Becton, Dickinson and Company
Glaxosmithkline PLc
3m
Merck & Co.
Sanofi
Segment by Type
Oral
Injectable
Topical
Ocular
Nasal
Pulmonary
Transmucosal
Implantable
Segment by Application
Hospitals
Ambulatory Surgical Centers
Home Care Settings
Diagnostic Centers
Others Facilities of Use
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Delivery Technology companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Delivery Technology Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injectable
1.2.4 Topical
1.2.5 Ocular
1.2.6 Nasal
1.2.7 Pulmonary
1.2.8 Transmucosal
1.2.9 Implantable
1.3 Market by Application
1.3.1 Global Drug Delivery Technology Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Home Care Settings
1.3.5 Diagnostic Centers
1.3.6 Others Facilities of Use
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Delivery Technology Market Perspective (2018-2029)
2.2 Drug Delivery Technology Growth Trends by Region
2.2.1 Global Drug Delivery Technology Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drug Delivery Technology Historic Market Size by Region (2018-2023)
2.2.3 Drug Delivery Technology Forecasted Market Size by Region (2024-2029)
2.3 Drug Delivery Technology Market Dynamics
2.3.1 Drug Delivery Technology Industry Trends
2.3.2 Drug Delivery Technology Market Drivers
2.3.3 Drug Delivery Technology Market Challenges
2.3.4 Drug Delivery Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Delivery Technology Players by Revenue
3.1.1 Global Top Drug Delivery Technology Players by Revenue (2018-2023)
3.1.2 Global Drug Delivery Technology Revenue Market Share by Players (2018-2023)
3.2 Global Drug Delivery Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Delivery Technology Revenue
3.4 Global Drug Delivery Technology Market Concentration Ratio
3.4.1 Global Drug Delivery Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Delivery Technology Revenue in 2022
3.5 Drug Delivery Technology Key Players Head office and Area Served
3.6 Key Players Drug Delivery Technology Product Solution and Service
3.7 Date of Enter into Drug Delivery Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Delivery Technology Breakdown Data by Type
4.1 Global Drug Delivery Technology Historic Market Size by Type (2018-2023)
4.2 Global Drug Delivery Technology Forecasted Market Size by Type (2024-2029)
5 Drug Delivery Technology Breakdown Data by Application
5.1 Global Drug Delivery Technology Historic Market Size by Application (2018-2023)
5.2 Global Drug Delivery Technology Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drug Delivery Technology Market Size (2018-2029)
6.2 North America Drug Delivery Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Drug Delivery Technology Market Size by Country (2018-2023)
6.4 North America Drug Delivery Technology Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Delivery Technology Market Size (2018-2029)
7.2 Europe Drug Delivery Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Drug Delivery Technology Market Size by Country (2018-2023)
7.4 Europe Drug Delivery Technology Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Delivery Technology Market Size (2018-2029)
8.2 Asia-Pacific Drug Delivery Technology Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Drug Delivery Technology Market Size by Region (2018-2023)
8.4 Asia-Pacific Drug Delivery Technology Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Delivery Technology Market Size (2018-2029)
9.2 Latin America Drug Delivery Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Drug Delivery Technology Market Size by Country (2018-2023)
9.4 Latin America Drug Delivery Technology Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Delivery Technology Market Size (2018-2029)
10.2 Middle East & Africa Drug Delivery Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Drug Delivery Technology Market Size by Country (2018-2023)
10.4 Middle East & Africa Drug Delivery Technology Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson Services
11.1.1 Johnson & Johnson Services Company Detail
11.1.2 Johnson & Johnson Services Business Overview
11.1.3 Johnson & Johnson Services Drug Delivery Technology Introduction
11.1.4 Johnson & Johnson Services Revenue in Drug Delivery Technology Business (2018-2023)
11.1.5 Johnson & Johnson Services Recent Development
11.2 Novartis Ag
11.2.1 Novartis Ag Company Detail
11.2.2 Novartis Ag Business Overview
11.2.3 Novartis Ag Drug Delivery Technology Introduction
11.2.4 Novartis Ag Revenue in Drug Delivery Technology Business (2018-2023)
11.2.5 Novartis Ag Recent Development
11.3 F.Hoffmann-La Roche Ltd.
11.3.1 F.Hoffmann-La Roche Ltd. Company Detail
11.3.2 F.Hoffmann-La Roche Ltd. Business Overview
11.3.3 F.Hoffmann-La Roche Ltd. Drug Delivery Technology Introduction
11.3.4 F.Hoffmann-La Roche Ltd. Revenue in Drug Delivery Technology Business (2018-2023)
11.3.5 F.Hoffmann-La Roche Ltd. Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Drug Delivery Technology Introduction
11.4.4 Pfizer Revenue in Drug Delivery Technology Business (2018-2023)
11.4.5 Pfizer Recent Development
11.5 Bayer Ag
11.5.1 Bayer Ag Company Detail
11.5.2 Bayer Ag Business Overview
11.5.3 Bayer Ag Drug Delivery Technology Introduction
11.5.4 Bayer Ag Revenue in Drug Delivery Technology Business (2018-2023)
11.5.5 Bayer Ag Recent Development
11.6 Antares PharmA
11.6.1 Antares PharmA Company Detail
11.6.2 Antares PharmA Business Overview
11.6.3 Antares PharmA Drug Delivery Technology Introduction
11.6.4 Antares PharmA Revenue in Drug Delivery Technology Business (2018-2023)
11.6.5 Antares PharmA Recent Development
11.7 Becton, Dickinson and Company
11.7.1 Becton, Dickinson and Company Company Detail
11.7.2 Becton, Dickinson and Company Business Overview
11.7.3 Becton, Dickinson and Company Drug Delivery Technology Introduction
11.7.4 Becton, Dickinson and Company Revenue in Drug Delivery Technology Business (2018-2023)
11.7.5 Becton, Dickinson and Company Recent Development
11.8 Glaxosmithkline PLc
11.8.1 Glaxosmithkline PLc Company Detail
11.8.2 Glaxosmithkline PLc Business Overview
11.8.3 Glaxosmithkline PLc Drug Delivery Technology Introduction
11.8.4 Glaxosmithkline PLc Revenue in Drug Delivery Technology Business (2018-2023)
11.8.5 Glaxosmithkline PLc Recent Development
11.9 3m
11.9.1 3m Company Detail
11.9.2 3m Business Overview
11.9.3 3m Drug Delivery Technology Introduction
11.9.4 3m Revenue in Drug Delivery Technology Business (2018-2023)
11.9.5 3m Recent Development
11.10 Merck & Co.
11.10.1 Merck & Co. Company Detail
11.10.2 Merck & Co. Business Overview
11.10.3 Merck & Co. Drug Delivery Technology Introduction
11.10.4 Merck & Co. Revenue in Drug Delivery Technology Business (2018-2023)
11.10.5 Merck & Co. Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Detail
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Drug Delivery Technology Introduction
11.11.4 Sanofi Revenue in Drug Delivery Technology Business (2018-2023)
11.11.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Johnson & Johnson Services
Novartis Ag
F.Hoffmann-La Roche Ltd.
Pfizer
Bayer Ag
Antares PharmA
Becton, Dickinson and Company
Glaxosmithkline PLc
3m
Merck & Co.
Sanofi

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂